Daily mesalamine as good as twice-a-day dosing for UC

11/8/2009 | Medscape (free registration)

Researchers said they were surprised to find that once-daily doses of delayed-release mesalamine were as effective at keeping ulcerative colitis in remission as a twice-a-day regimen. The study, presented at the ACG Annual Scientific Meeting, also showed daily dosing improved patient compliance.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL